CeloNova signs deal with HealthTrust for new coronary stent

Image: The nanocoated coronary stent is designed to help physicians treat patients who may benefit from short, one-month minimum dual antiplatelet therapy. Photo: courtesy of hywards / FreeDigitalPhotos.net.